School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053 Zhejiang, China.
School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053 Zhejiang, China.
J Food Drug Anal. 2024 Mar 15;32(1):79-102. doi: 10.38212/2224-6614.3492.
Guhong injection (GHI) has been applied in the therapy of cardio-cerebrovascular disease in clinic, but there is no report about the pharmacokinetic/pharmacodynamic (PK/PD) research on GHI treating myocardial ischemia/reperfusion (MI/R) injury in rats. In this study, eight compounds of GHI in plasma, including N-acetyl-L-glutamine (NAG), chlorogenic acid (CGA), hydroxysafflor yellow A (HSYA), p-coumaric acid ( pCA), rutin, hyperoside, kaempferol-3-O-rutinoside, and kaempferol-3-O-glucoside, were quantified by LC-MS/MS. We discovered that the values of t, k, V, and CL were larger than those of t, k, V, and CL for all compounds. The levels of four biomarkers, creatine kinase-MB (CK-MB), cardiac troponin I (cTn I), ischemia-modified albumin (IMA), and alpha-hydroxybutyrate dehydrogenase (α-HBDH) in plasma were determined by ELISA. The elevated level of these biomarkers induced by MI/R was declined to different degrees via administrating GHI and verapamil hydrochloride (positive control). The weighted regression coefficients of NAG, HSYA, CGA, and pCA in PLSR equations generated from The Unscrambler X software (version 11) were mostly minus, suggesting these four ingredients were positively correlated to the diminution of the level of four biomarkers. E and ED, two parameters in PK/PD equations that were obtained by adopting Drug and Statistics software (version 3.2.6), were almost enlarged with the rise of GHI dosage. Obviously, all analytes were dominantly distributed and eliminated in the peripheral compartment with features of rapid distribution and slow elimination. With the enhancement of GHI dosage, the ingredients only filled in the central compartment if the peripheral compartment was replete. Meanwhile, high-dose of GHI generated the optimum intrinsic activity, but the affinity of compounds with receptors was the worst, which may be caused by the saturation of receptors. Among the eight analytes, NAG, HSYA, CGA, and pCA exhibited superior cardioprotection, which probably served as the pharmacodynamic substance basis of GHI in treating MI/R injury.
古红注射液(GHI)已在临床用于治疗心脑血管疾病,但尚无关于 GHI 治疗大鼠心肌缺血/再灌注(MI/R)损伤的药代动力学/药效学(PK/PD)研究的报道。在这项研究中,我们采用 LC-MS/MS 定量测定了 GHI 血浆中的 8 种化合物,包括 N-乙酰-L-谷氨酰胺(NAG)、绿原酸(CGA)、羟基红花黄色 A(HSYA)、对香豆酸(pCA)、芦丁、槲皮苷、山奈酚-3-O-芦丁糖苷和山奈酚-3-O-葡萄糖苷。我们发现,所有化合物的 t、k、V 和 CL 值均大于 t、k、V 和 CL。通过 ELISA 测定了血浆中 4 种生物标志物肌酸激酶同工酶-MB(CK-MB)、心肌肌钙蛋白 I(cTn I)、缺血修饰白蛋白(IMA)和α-羟丁酸脱氢酶(α-HBDH)的水平。通过给予 GHI 和盐酸维拉帕米(阳性对照),不同程度地降低了由 MI/R 引起的这些生物标志物的升高水平。来自 Unscrambler X 软件(版本 11)的 PLSR 方程中 NAG、HSYA、CGA 和 pCA 的加权回归系数大多为负数,表明这四种成分与四种生物标志物水平的降低呈正相关。PK/PD 方程中的 E 和 ED 两个参数是通过采用 Drug and Statistics 软件(版本 3.2.6)获得的,随着 GHI 剂量的增加,这两个参数几乎都增大了。显然,所有分析物主要分布和消除在外周隔室,具有快速分布和缓慢消除的特征。随着 GHI 剂量的增加,如果外周隔室充满,则只有成分填充中央隔室。同时,高剂量的 GHI 产生了最佳的内在活性,但化合物与受体的亲和力最差,这可能是由于受体饱和所致。在这 8 种分析物中,NAG、HSYA、CGA 和 pCA 表现出较好的心脏保护作用,这可能是 GHI 治疗 MI/R 损伤的药效物质基础。